CSF3 and glioblastoma: Potentially, this contrasting predictive effect is linked to the secretion by GBM cells of Granulocyte-Colony Stimulating Factor (G-CSF), a growth factor for neutrophils that is also responsible for a specific type of angiogenesis that correlates to bevacizumab overall survival (OS) benefit [29].